BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10439523)

  • 1. Widespread plaque psoriasis responsive to mycophenolate mofetil.
    Tong DW; Walder BK
    Australas J Dermatol; 1999 Aug; 40(3):135-7. PubMed ID: 10439523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic plaque-stage psoriasis and psoriatic arthritis with mycophenolate mofetil.
    Grundmann-Kollmann M; Mooser G; Schraeder P; Zollner T; Kaskel P; Ochsendorf F; Boehncke WH; Kerscher M; Kaufmann R; Peter RU
    J Am Acad Dermatol; 2000 May; 42(5 Pt 1):835-7. PubMed ID: 10775866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasis and psoriatic arthritis in a patient with HIV: response to mycophenolate mofetil treatment.
    Forman SB; Higginson R; Garrett AB
    J Drugs Dermatol; 2008 Oct; 7(10):972-3. PubMed ID: 19112763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preliminary results in the therapy of psoriatic arthritis with mycophenolate mofetil].
    Schräder P; Mooser G; Peter RU; Puhl W
    Z Rheumatol; 2002 Oct; 61(5):545-50. PubMed ID: 12399882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mycophenolate mofetil: a new immunosuppressive drug in dermatology and its possible uses].
    Geilen CC; Orfanos-Boeckel H; Offermann G; Orfanos CE
    Hautarzt; 2000 Feb; 51(2):63-9. PubMed ID: 10743574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical application of mycophenolate mofetil in plaque-type psoriasis.
    Wohlrab J; Jahn K; Plaetzer M; Neubert R; Marsch WC
    Br J Dermatol; 2001 Jun; 144(6):1263-4. PubMed ID: 11422055
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined mycophenolate mofetil and cyclosporin therapy for severe recalcitrant psoriasis.
    Ameen M; Smith HR; Barker JN
    Clin Exp Dermatol; 2001 Sep; 26(6):480-3. PubMed ID: 11678869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential study on the treatment of moderate-to-severe chronic plaque psoriasis with mycophenolate mofetil and cyclosporin.
    Pedraz J; Daudén E; Delgado-Jiménez Y; García-Río I; García-Díez A
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):702-6. PubMed ID: 16836499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis.
    Sobrin L; Christen W; Foster CS
    Ophthalmology; 2008 Aug; 115(8):1416-21, 1421.e1. PubMed ID: 18221998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of erythrodermic psoriasis with mycophenolate mofetil.
    Geilen CC; Tebbe B; Garcia Bartels C; Krengel S; Orfanos CE
    Br J Dermatol; 1998 Jun; 138(6):1101-2. PubMed ID: 9747391
    [No Abstract]   [Full Text] [Related]  

  • 11. Change of treatment from cyclosporin to mycophenolate mofetil in severe psoriasis.
    Davison SC; Morris-Jones R; Powles AV; Fry L
    Br J Dermatol; 2000 Aug; 143(2):405-7. PubMed ID: 10951153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil for psoriasis.
    Kirby B; Yates VM
    Br J Dermatol; 1998 Aug; 139(2):357. PubMed ID: 9767269
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe generalized pustular psoriasis treated with mycophenolate mofetil.
    Ji YZ; Geng L; Ma XH; Wu Y; Zhou HB; Li B; Xiao T; Chen HD
    J Dermatol; 2011 Jun; 38(6):603-5. PubMed ID: 21352286
    [No Abstract]   [Full Text] [Related]  

  • 14. Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses.
    Kitchin JE; Pomeranz MK; Pak G; Washenik K; Shupack JL
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):445-9. PubMed ID: 9308561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis vulgaris treated successfully with mycophenolate mofetil.
    Haufs MG; Beissert S; Grabbe S; Schütte B; Luger TA
    Br J Dermatol; 1998 Jan; 138(1):179-81. PubMed ID: 9536244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma trough levels of mycophenolic acid do not correlate with efficacy and safety of mycophenolate mofetil in psoriasis.
    Daudén E; Sánchez-Peinado C; Ruiz-Genao D; García-F-Villalta M; Onate MJ; García-Díez A
    Br J Dermatol; 2004 Jan; 150(1):132-5. PubMed ID: 14746627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistent psoriasis and bullous pemphigoid responding to mycophenolate mofetil monotherapy.
    Rallis E; Anyfantakis V
    Skinmed; 2008; 7(2):101-2. PubMed ID: 18327004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil (CellCept) for psoriasis: a two-center, prospective, open-label clinical trial.
    Zhou Y; Rosenthal D; Dutz J; Ho V
    J Cutan Med Surg; 2003; 7(3):193-7. PubMed ID: 12704533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation.
    Fulton B; Markham A
    Drugs; 1996 Feb; 51(2):278-98. PubMed ID: 8808168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of mycophenolate mofetil with ciclosporine for the treatment of chronic plaque-type psoriasis.
    Beissert S; Pauser S; Sticherling M; Frieling U; Loske KD; Frosch PJ; Haase I; Luger TA
    Dermatology; 2009; 219(2):126-32. PubMed ID: 19546522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.